4/3
08:00 am
pepg
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc - PEPG
High
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc - PEPG
4/2
04:13 pm
pepg
PepGen to Present at the 24th Annual Needham Virtual Healthcare Conference [Yahoo! Finance]
High
Report
PepGen to Present at the 24th Annual Needham Virtual Healthcare Conference [Yahoo! Finance]
4/2
04:05 pm
pepg
PepGen to Present at the 24th Annual Needham Virtual Healthcare Conference
High
Report
PepGen to Present at the 24th Annual Needham Virtual Healthcare Conference
3/31
04:17 pm
pepg
PepGen Announces Appointment of Two New Directors to its Board [Yahoo! Finance]
Medium
Report
PepGen Announces Appointment of Two New Directors to its Board [Yahoo! Finance]
3/31
04:05 pm
pepg
PepGen Announces Appointment of Two New Directors to its Board
Medium
Report
PepGen Announces Appointment of Two New Directors to its Board
3/30
08:00 am
pepg
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc - PEPG
High
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc - PEPG
3/26
08:00 am
pepg
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc - PEPG
Medium
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc - PEPG
3/25
10:00 am
pepg
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc - PEPG
High
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc - PEPG
3/17
12:28 pm
pepg
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc - PEPG
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc - PEPG
3/10
04:33 pm
pepg
PepGen Announces Presentations at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference [Yahoo! Finance]
High
Report
PepGen Announces Presentations at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference [Yahoo! Finance]
3/10
04:05 pm
pepg
PepGen Announces Presentations at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference
High
Report
PepGen Announces Presentations at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference
3/4
08:05 am
pepg
PepGen to Participate in Upcoming Investor Conferences
High
Report
PepGen to Participate in Upcoming Investor Conferences
3/4
08:00 am
pepg
PepGen Announces Update to Phase 2 CONNECT2-EDO51 Study in Patients with DMD
High
Report
PepGen Announces Update to Phase 2 CONNECT2-EDO51 Study in Patients with DMD
2/24
12:35 pm
pepg
PepGen Inc. (NASDAQ: PEPG) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
High
Report
PepGen Inc. (NASDAQ: PEPG) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
2/24
07:42 am
pepg
PepGen Reports Fourth Quarter and Year-End 2024 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
High
Report
PepGen Reports Fourth Quarter and Year-End 2024 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
2/24
07:30 am
pepg
PepGen Reports Fourth Quarter and Year-End 2024 Financial Results and Recent Corporate Highlights
High
Report
PepGen Reports Fourth Quarter and Year-End 2024 Financial Results and Recent Corporate Highlights
2/24
07:12 am
pepg
PepGen Announces Positive Initial Results, Including Robust Splicing Correction, from Ongoing FREEDOM-DM1 Trial in Patients with DM1 [Yahoo! Finance]
High
Report
PepGen Announces Positive Initial Results, Including Robust Splicing Correction, from Ongoing FREEDOM-DM1 Trial in Patients with DM1 [Yahoo! Finance]
2/24
07:00 am
pepg
PepGen Announces Positive Initial Results, Including Robust Splicing Correction, from Ongoing FREEDOM-DM1 Trial in Patients with DM1
High
Report
PepGen Announces Positive Initial Results, Including Robust Splicing Correction, from Ongoing FREEDOM-DM1 Trial in Patients with DM1
2/4
04:30 pm
pepg
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
Medium
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
2/1
10:00 am
pepg
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
Medium
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
1/30
12:00 pm
pepg
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
Medium
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
1/30
08:18 am
pepg
PepGen Inc. (NASDAQ: PEPG) had its price target lowered by analysts at HC Wainwright from $26.00 to $16.00. They now have a "buy" rating on the stock.
High
Report
PepGen Inc. (NASDAQ: PEPG) had its price target lowered by analysts at HC Wainwright from $26.00 to $16.00. They now have a "buy" rating on the stock.
1/29
04:05 pm
pepg
PepGen Announces CONNECT Program Updates
High
Report
PepGen Announces CONNECT Program Updates
1/28
01:10 pm
pepg
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
Medium
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
1/26
12:00 pm
pepg
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
Medium
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG